CARE vs EQBK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

CARE

66.6
AI Score
VS
CARE Wins

EQBK

65.0
AI Score

Investment Advisor Scores

CARE

67score
Recommendation
HOLD

EQBK

65score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE EQBK Winner
Forward P/E 13.6612 10.3842 EQBK
PEG Ratio 0 1.6942 Tie
Revenue Growth 68.3% 38.1% CARE
Earnings Growth 253.9% 47.7% CARE
Tradestie Score 66.6/100 65.0/100 CARE
Profit Margin 44.9% 14.7% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CARE 1M: -2.7% · 3M: -7.4% EQBK 1M: -3.7% · 3M: -2.5%

Current Technical Phase

CARE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 48.8 · Price: $30.75

EQBK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 38

RSI (14): 38.0 · Price: $47.73

Fundamentals Snapshot

Metric CARE EQBK
Market Cap — —
Forward P/E 11.8 8.7
Trailing P/E 5.2 30.2
Revenue (TTM) — —
Revenue Growth 0.7% 0.4%
Gross Margin 1.0% 1.0%
Operating Margin 0.6% 0.5%
EPS 5.89 1.57
Dividend Yield 0.00% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CARE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.